Table 1 Clinical characteristics of patients.
AOSD (n = 20) | HC (n = 15) | p-value | |
|---|---|---|---|
Age (years) | 50.1 ± 13.6 | 43.2 ± 7.8 | 0.069 |
Gender (F/M) | 13/7 | 7/8 | 0.321 |
Systemic manifestation/chronic articular manifestation | 15/5 | ||
Fever | 10 (50) | ||
Sore throat | 4 (20) | ||
Skin rash | 12 (60) | ||
Lymphadenopathy | 3 (15) | ||
Splenomegaly | 2 (10) | ||
Hepatomegaly | 2 (10) | ||
Pericarditis | 0 (0) | ||
Arthritis | 6 (30) | ||
Hemoglobin, g/dL | 12.7 ± 1.7 | ||
Leukocytes, /μL | 9,515 ± 4,570 | ||
Neutrophils, /μL | 7,306 ± 4,447 | ||
Platelets, × 103/μL | 287.7 ± 137.0 | ||
Ferritin, ng/mL | 2,137.6 ± 4,512.0 | ||
ESR, mm/h | 37.1 ± 31.8 | ||
CRP, mg/dL | 5.63 ± 9.06 | ||
AST/ALT, mg/dL | 39.7 ± 39.1/34.8 ± 27.4 | ||
Bilirubin, mg/dL | 0.55 ± 0.31 | ||
Albumin, g/dL | 4.2 ± 0.6 | ||
Systemic score | 2.5 ± 1.9 | ||
IL-1β, pg/mL | 1.86 ± 5.99 | 0.00 ± 0.00 | 0.214 |
IL-6, pg/mL | 9.56 ± 15.1 | 0.00 ± 0.00 | 0.012 |
IL-18, ng/mL | 7.47 ± 6.44 | 0.44 ± 0.34 | < 0.001 |
TNF-α, pg/mL | 4.54 ± 7.65 | 0.42 ± 1.25 | 0.086 |